NYSE: ALB

Albemarle (ALB) Stock Analysis & Forecast

Nov 13 close

$93.53−1.32 (−1.4%)

Gekko Brief

AI summaryNov 9 close

Albemarle's week centered on third-quarter results reported 4 November, with net sales of $1.6B, up 19% year over year, and adjusted EBITDA of $646 million, up 186%, as EBITDA margin expanded to 42%. Energy storage EBITDA surged 351% on higher lithium pricing, while specialties rose 31% on price and volume gains, and the call highlighted $150M+ in cost savings and YTD free cash flow of $1.2 billion. Analyst reaction was mixed on price targets: RBC Capital maintained Outperform but lowered its target to $119 from $129, BMO Capital cut its target to $160 from $175 while keeping Outperform and raising its 2027 EBITDA estimate to $2.1 billion, and a separate consensus of 18 analysts cut the average 12-month target to $138.11 from $141.22 while keeping a Buy rating among 24 covering analysts.

The stock closed at $99.12, down 0.1%, sitting below both its 50-day average of $106.78 and 200-day average of $147.51, with the 50-day also below the 200-day. The GekkoIndex reads 58, placing it in the Neutral zone, down 11.3 over five days. Price sits 21.5% below Gekko Fair Value of $126.22.

Earnings are not due again until 10 February 2027, 92 days out, placing the event outside a typical 20-day holding window. Over the last 90 days, Congress recorded 1 buy and 0 sells, while the last 30 days show 2 unusual options signals with call premium of $1,630,346 against put premium of $7,261. Seasonally, the next 20 trading days have averaged +3.1% over 5 years, rising in 2 of those years, a pattern worth noting alongside the wide gap to fair value.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Albemarle price vs fair value

$117.88$93.53Nov ’25May ’26Nov ’26
Close $93.53200-day averageGekko Fair Value $117.88

Albemarle quick facts

Market cap
$11.04B
P/E ratio
22.9
Forward P/E
9.7
EPS, TTM
$4.15
Revenue, TTM
$6.15B
Profit margin
11.1%
Dividend yield
1.69%
Beta
1.36
Volume
1.18M avg 2.45M
1-year return
−15.2%
Typical daily move
±4.2%
Typical 20-day move
±11.3%
50-day average
$103.56
200-day average
$145.66
Next earnings
Feb 10 after close
Shares outstanding
118.0M
52-week range
$89.77$221.00

Albemarle swing-trade checklist

Albemarle scores 4 supportive, 0 mixed and 2 headwinds across the 6 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive0 mixed2 headwinds

  • Trendheadwind

    Below 50 and 200-day

    Close $93.53 is below the 50-day ($103.56) and 200-day ($145.66) averages, and the 50-day is below the 200-day.

    See the chart
  • GekkoIndexsupportive

    62.9, Accumulation

    Reading 62.9 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    20.7% below

    Price is 20.7% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneysupportive

    Leans bullish

    Last 90 days: Congress 1 buy / 0 sales. Last 30 days: 1 unusual options signal.

    See smart money
  • Earnings risksupportive

    Reports in 87 days

    Next report Feb 10, 2027, 87 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityheadwind

    −1.0% on average

    From this point in the calendar, the next 20 trading days averaged −1% over 5 years, rising in 2 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Albemarle stock chart and price history

Albemarle closed at $93.53 on Nov 13, 2026, −15.2% over the past year, inside a 52-week range of $89.77 to $221.00.

Close50-day average200-day averageVolume
Albemarle share price, past year, with 50-day and 200-day moving averages and volume$150$200DecJan 2026FebMarAprMayJunJulAugSepOctNov93.53

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−4.7%
3 months
−30.2%
6 months
−48.1%
1 year
−15.2%
The full ALB chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ALB in Gekko

Follow Albemarle through every session

Put ALB on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track ALB in GekkoFree for 7 days. No credit card required.

About Albemarle

Albemarle produces specialty chemicals that feed into many industrial and consumer products. Its lithium business turns out compounds like carbonate, hydroxide, and chloride, materials that go into batteries powering electric vehicles and electronic devices, plus reagents such as butyllithium used in synthesis for steroids, vitamins, and pharmaceutical work. That same business line supplies cesium for chemical and drug uses, along with zirconium, barium, and titanium destined for pyrotechnic components like airbag triggers, and it backs these products with handling guidance and recycling services for lithium waste streams.

Beyond lithium, Albemarle runs a bromine business making elemental bromine, bromide compounds, and activated carbon products applied in drilling fluids, mercury capture, water treatment, and food handling, alongside amine ingredients used in surfactants and disinfectants. A third business area, catalysts, covers agents for refining steps such as hydroprocessing, isomerization, and alkylation, plus fluid catalytic cracking materials and organometallic compounds. Together these offerings serve sectors like energy storage, refining, electronics, building materials, vehicles, lubricants, drug manufacturing, and agriculture.

The company traces back to 1887 and runs its headquarters out of Charlotte, North Carolina. Albemarle trades on the NYSE under the ticker ALB.

Listed
NYSE
Sector
Process industries
Industry
Chemicals: specialty
Website
albemarle.com

Albemarle GekkoIndex: the smart money zone

Albemarle’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 62.9, in the Accumulation zone, up 4.3 points over five sessions.

010062.9Accumulation

Up 4.3 points over five sessions, from the Neutral zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying76+0.1%+0.1%−0.1%−5.1%
Accumulation (current zone)248−0.8%−1.4%−2.6%−2.7%
Neutral354+0.8%+0.9%+2.2%+6.6%
Distribution23+0.4%+5.4%+7.0%+12.1%
Selling1Too few readings yet

Average ALB share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the ALB price, zone by zone.Track ALB in Gekko

Is Albemarle stock overvalued? Gekko Fair Value

Albemarle trades 20.7% below Gekko Fair Value of $117.88, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Albemarle shares are worth, recalculated every trading day.

$117.88

Gekko Fair Value, Nov 14, 2026

20.7% Undervalued

At the end of Aug 2026 the price was 14.3% below the estimate.

Gekko Fair ValueShare price, month end
$118$94Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open ALB in Gekko

Albemarle insider and Congress trading

No open-market insider purchases were filed for Albemarle, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for ALB in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every ALB insider filing, plotted on the chart in Gekko.Open ALB in Gekko

Congress trades last 90 days

1trade disclosed: 1 purchase and 0 sales.

MemberTypeAmountDisclosed
Ro Khanna
House, CA, purchase
Purchase$1,001 - $15,000Oct 9
traded Sep 25

From congressional disclosures, which report amounts as ranges.

Buybacks

Albemarle has been buying back its own shares.

Bought back, quarter ended Mar 31, 2026
$3.94M
As a share of market cap
0.04%

From company filings.

Unusual options activity last 30 days

1signal, 100% of the flagged premium in calls.

Latest: Bullish flow on Oct 17, $495K in unusual premium.

Hedge funds and billionaires quarter ended Jun 30

0of the funds Gekko tracks hold ALB.

0added0opened0trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko

Albemarle earnings: next date and track record

Albemarle reports on Feb 10, 2027, after the close (87 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±4.2%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

+4.7%Feb ’25−0.2%Apr ’25−5.2%Jul ’25+3.2%Nov ’25−5.7%Feb ’26+1.8%May ’26+3.8%Aug ’26+9.1%Nov ’26

Last earnings call, Nov 4, 2026 AI summary

What they said
ALB reported Q3 2026 net sales of $1.6B (up 19% YoY) and adjusted EBITDA of $646M (up 186% YoY), with EBITDA margin expanding to 42%. Adjusted EPS was $2.58. Energy storage EBITDA surged 351% on higher lithium pricing, while specialties rose 31% on price and volume gains. YTD free cash flow reached $1.2B with $150M+ in cost savings achieved. Global lithium consumption grew 48% YTD.
Guidance
ALB raised its 2026 adjusted EBITDA outlook for specialties and reduced full-year capex through capital efficiency measures. Management targets continued cost improvements, with YTD results trending toward the high end of the $20/kg LCE pricing scenario.
ReportedEPSSurpriseRevenueSurpriseMove
Nov 4, 2026$2.58
est $2.53
+2.0%$1.55B
est $1.52B
+2.3%+9.1%
Aug 5, 2026$3.75
est $3.35
+11.9%$1.74B
est $1.61B
+8.5%+3.8%
May 6, 2026$2.95
est $1.31
+125.2%$1.43B
est $1.34B
+6.6%+1.8%
Feb 11, 2026−$0.53
est −$0.42
−26.9%$1.43B
est $1.35B
+6.0%−5.7%
Nov 5, 2025−$0.19
est −$0.86
+77.9%$1.31B
est $1.28B
+2.4%+3.2%
Jul 30, 2025$0.11
est −$0.83
+113.3%$1.33B
est $1.27B
+4.6%−5.2%
Apr 30, 2025−$0.18
est −$0.62
+71.0%$1.08B
est $1.16B
−7.5%−0.2%
Feb 12, 2025−$1.09
est −$0.60
−81.7%$1.23B
est $1.34B
−7.8%+4.7%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Albemarle stock forecast and analyst price targets

Analysts’ average 12-month price target for Albemarle is $139.35, +49.0% from the last close, from 14 firms rating the stock in the last 90 days.

$139.35consensus 12-month target, +49.0% from the last close
Low $95High $211
Buy11
Hold3
Sell0

Each firm’s latest rating in the last 90 days: 14 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 13DBSBuy, maintained$135+44.3%
Nov 12Bank of America SecuritiesBuy, maintained$120+28.3%
Nov 11Bank of America SecuritiesBuy, reiterated$120+28.3%
Nov 9ScotiabankBuy, maintained$165+76.4%
Nov 9Deutsche Bank Buy, maintained$125+33.6%
−2.6%average 20-day move after past Accumulation readings
−1.0%average move over the next 20 trading days in the last 5 years
±4.2%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Albemarle seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Albemarle averaged −1.0% across the last 5 years, rising in 2 of them.

Next 20 trading days, by year

−10.1%2021−17.2%2022+11.8%2023−2.7%2024+14.8%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−0.5%4 of 5
Next 10 trading days−1.3%1 of 5
Next 15 trading days−4.9%1 of 5
Next 20 trading days−1.0%2 of 5
Next 30 trading days−4.5%2 of 5

For scale, ALB’s typical 20-trading-day move in either direction is about 11.3%.

Albemarle market cap and key statistics

Albemarle’s market cap is $11.04B, with a P/E ratio of 22.9 and revenue of $6.15B over the last twelve months.

Valuation

Market cap
$11.04B
P/E ratio
22.9
Forward P/E
9.7
EPS, TTM
$4.15
Gekko Fair Value
$117.88

Trading

Volume
1.18M
Avg volume, 20 days
2.45M
52-week high
$221.00
52-week low
$89.77
Shares outstanding
118.0M

Financials

Revenue, TTM
$6.15B
Profit margin
11.1%
Return on equity
7%
Quarterly earnings growth, YoY
−66.2%

Risk and income

Beta
1.36
Typical daily move
±4.2%
Typical 20-day move
±11.3%
Dividend yield
1.69%

Albemarle peers

Albemarle’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
LINLinde0.0%Neutral4.8% above
ECLEcolab−0.1%Neutral16.6% above
APDAir Products and Chemicals−0.6%Neutral0.5% above
DOWDow−0.7%Neutral23.9% below
LYBLyondellBasell Industries+0.1%Neutral6.5% below
WLKWestlake+0.8%Accumulation22.5% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Chemicals: specialty

Albemarle stock FAQ

What is Albemarle’s market cap?

Albemarle’s market cap is $11.04B at the Nov 13, 2026 close of $93.53, with 118.0M shares outstanding. The shares trade on a P/E ratio of 22.9.

What is the Albemarle stock forecast?

The consensus analyst 12-month price target for Albemarle is $139.35, +49.0% from the last close. Of the 14 firms that rated the stock in the last 90 days, 11 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Albemarle stock overvalued or undervalued?

On Gekko’s estimate Albemarle is undervalued: the Nov 13, 2026 close of $93.53 is 20.7% below Gekko Fair Value of $117.88. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Albemarle report earnings next?

Albemarle is expected to report on Feb 10, 2027, after the market closes (87 days away). Analysts expect earnings of $1.44 per share on revenue of $1.37B. Albemarle beat the earnings estimate in 6 of its last 8 reports, moving 4.2% on average across the report.

What is Albemarle’s 52-week high and low?

Albemarle’s 52-week high is $221.00 and its 52-week low is $89.77; it closed at $93.53 on Nov 13, 2026, −15.2% over the past year. Over the last five years the shares peaked at $334.55 on Nov 11, 2022.

Is Albemarle stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.

Is there unusual options activity in Albemarle?

Gekko flagged 1 unusual options signal in Albemarle over the last 30 days, with $495K of flagged premium in calls and $0 in puts. The latest, bullish flow, was on Oct 17, 2026 with $495K in unusual premium. The signal-by-signal table is in Gekko.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Albemarle the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.